Correlation Between HANSOH PHARMAC and Phibro Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HANSOH PHARMAC and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HANSOH PHARMAC and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HANSOH PHARMAC HD 00001 and Phibro Animal Health, you can compare the effects of market volatilities on HANSOH PHARMAC and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HANSOH PHARMAC with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of HANSOH PHARMAC and Phibro Animal.

Diversification Opportunities for HANSOH PHARMAC and Phibro Animal

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between HANSOH and Phibro is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding HANSOH PHARMAC HD 00001 and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and HANSOH PHARMAC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HANSOH PHARMAC HD 00001 are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of HANSOH PHARMAC i.e., HANSOH PHARMAC and Phibro Animal go up and down completely randomly.

Pair Corralation between HANSOH PHARMAC and Phibro Animal

Assuming the 90 days horizon HANSOH PHARMAC is expected to generate 1.02 times less return on investment than Phibro Animal. In addition to that, HANSOH PHARMAC is 1.07 times more volatile than Phibro Animal Health. It trades about 0.13 of its total potential returns per unit of risk. Phibro Animal Health is currently generating about 0.15 per unit of volatility. If you would invest  1,960  in Phibro Animal Health on November 6, 2024 and sell it today you would earn a total of  120.00  from holding Phibro Animal Health or generate 6.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HANSOH PHARMAC HD 00001  vs.  Phibro Animal Health

 Performance 
       Timeline  
HANSOH PHARMAC HD 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in HANSOH PHARMAC HD 00001 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, HANSOH PHARMAC may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Phibro Animal Health 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Phibro Animal is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

HANSOH PHARMAC and Phibro Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HANSOH PHARMAC and Phibro Animal

The main advantage of trading using opposite HANSOH PHARMAC and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HANSOH PHARMAC position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.
The idea behind HANSOH PHARMAC HD 00001 and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like